Rayaldee is now approved! Visit the new Rayaldee Web Site  

Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism


Recent News:

OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients
August 30, 2021

OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients
September 15, 2020

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients
June 01, 2020




© 2021 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use